Allarity Therapeutics Schedules Q3 2026 Earnings Announcement
Allarity Therapeutics, Inc. is scheduled to release its financial results for the third quarter of 2026 on November 12, 2026.
Stocks · News reference
Lobo Technologies shares surged 32% premarket after a narrower H1 loss and higher sales; several small caps rallied while others fell sharply.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Allarity Therapeutics, Inc. is scheduled to release its financial results for the third quarter of 2026 on November 12, 2026.
NextNRG, Inc. has signed a non-binding term sheet to acquire a 33-acre site in South Bend, Indiana, to develop a new energy and data center facility.
IM Cannabis Corp. closed a US$1.2 million convertible note financing with an existing institutional investor, featuring a 15% original issuance discount and warrants for 3,936,330 shares.
LOBO Technologies Ltd. reported securing new overseas orders for its electric vehicle models following a successful showcase at the 140th China Import and Export Fair.
Filed: 2026-11-04 AccNo: 0001104659-26-122719 Size: 212 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Gainers Revolution Medicines (NASDAQ:RVMD) stock rose 14.1% to $227.83 during Wednesday's after-market session. The market value of their outstanding shares is at $41.6 billion. As per the news, the Q3 earnings